Ajanta Pharmaceuticals Ltd. — filings
Every filing on record for this company. Each row opens the document it names.
| Filing | Period | Scope / kind | Filed | Document |
|---|---|---|---|---|
| Results XBRL (NSE) | 2018-03-31 | Standalone | — | INDAS_34782_8032_03052018024305_WEB.xml |
| Results XBRL (NSE) | 2018-03-31 | Consolidated | — | INDAS_34782_8032_03052018024305_WEB_2.xm |
| Results XBRL (NSE) | 2018-09-30 | Standalone | — | INDAS_39942_56927_01112018045414_WEB.xml |
| Results XBRL (NSE) | 2018-09-30 | Consolidated | — | INDAS_39942_56927_01112018045414_WEB_2.x |
| Results XBRL (NSE) | 2018-12-31 | Standalone | — | INDAS_43487_83972_22022019031335_WEB.xml |
| Results XBRL (NSE) | 2018-12-31 | Consolidated | — | INDAS_43487_83972_22022019031335_WEB_2.x |
| Results XBRL (NSE) | 2019-03-31 | Consolidated | — | INDAS_43735_100286_02052019033423_WEB.xm |
| Results XBRL (NSE) | 2019-03-31 | Standalone | — | INDAS_43736_100288_02052019033806_WEB.xm |
| Results XBRL (NSE) | 2019-06-30 | Standalone | — | INDAS_46510_127005_01082019103238_WEB.xm |
| Results XBRL (NSE) | 2019-06-30 | Consolidated | — | INDAS_46511_127008_01082019103509_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Consolidated | — | INDAS_49299_160334_06112019112152_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Standalone | — | INDAS_49301_160341_06112019112336_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Consolidated | — | INDAS_52553_215323_06022020105908_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Standalone | — | INDAS_52554_215326_06022020110017_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_55244_260064_21052020120333_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_55245_260068_21052020120544_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_58749_300082_31072020103644_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_58751_300088_31072020103817_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_63026_354416_04112020032417_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_63027_354420_04112020032538_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_66855_401305_03022021100416_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_66856_401308_03022021100530_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_69606_445414_01052021023807_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_69607_445417_01052021024000_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_73700_497708_30072021121917_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_73702_497714_30072021122031_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_77479_549914_01112021093820_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_77486_549961_01112021113442_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_80844_601279_31012022054101_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_80845_601282_31012022054235_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_84211_652827_11052022105530_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_84212_652830_11052022105723_WEB.xm |
| Results XBRL (NSE) | 2022-06-30 | Consolidated | — | INDAS_612189_2809_29072022102050_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_838025_5150_04112022165850_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_838026_5150_04112022165850_WEB.xml |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_88323_783458_02022023111250_WEB.xm |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_88324_783463_02022023111421_WEB.xm |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_91250_837984_05052023055426.xml |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_91251_837987_05052023055622.xml |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_94723_901926_27072023071356.xml |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_94725_901939_27072023071558.xml |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_98318_972344_31102023052756.xml |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_98320_972364_31102023053643.xml |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_101935_1040889_31012024081329.xml |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_101936_1040896_31012024081644.xml |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_105172_1114070_02052024074347.xml |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_105173_1114087_02052024075035.xml |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_109792_1206475_30072024041326.xml |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_109832_1206826_30072024060010.xml |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_113747_1291825_29102024111731.xml |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_113749_1291841_29102024112224.xml |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_118161_1366089_30012025051110.xml |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_118165_1366143_30012025052543.xml |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1429258_30042025 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1429340_30042025 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1495181_28072025 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1495199_28072025 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1563647_03112025 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1563791_03112025 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1614462_30012026 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1614540_30012026 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1663654_05052026 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1663679_05052026 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1705073_30072026 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1705089_30072026 |
| Results XBRL (BSE) | 2018-06-30 | Standalone | 2018-07-31T17:06:41 | Main_Ind_As_532331_317201817626.xml |
| Results XBRL (BSE) | 2018-06-30 | Consolidated | 2018-07-31T17:06:41 | Main_Ind_As_532331_317201817716.xml |
| Results XBRL (BSE) | 2018-09-30 | Standalone | 2018-11-01T10:25:02 | Main_Ind_As_532331_1112018102444.xml |
| Results XBRL (BSE) | 2018-09-30 | Consolidated | 2018-11-01T10:25:02 | Main_Ind_As_532331_1112018102556.xml |
| Results XBRL (BSE) | 2018-12-31 | Standalone | 2019-01-31T12:10:33 | Main_Ind_As_532331_3112019121015.xml |
| Results XBRL (BSE) | 2018-12-31 | Consolidated | 2019-01-31T12:10:33 | Main_Ind_As_532331_311201912917.xml |
| Results XBRL (BSE) | 2019-03-31 | Consolidated | 2019-05-02T11:39:47 | Main_Ind_As_532331_252019113545.xml |
| Results XBRL (BSE) | 2019-03-31 | Standalone | 2019-05-02T11:39:47 | Main_Ind_As_532331_252019113844.xml |
| Results XBRL (BSE) | 2019-06-30 | Standalone | 2019-08-01T10:22:40 | Main_Ind_As_532331_182019102230.xml |
| Results XBRL (BSE) | 2019-06-30 | Consolidated | 2019-08-01T10:22:40 | Main_Ind_As_532331_182019102259.xml |
| Results XBRL (BSE) | 2019-09-30 | Consolidated | 2019-11-06T12:13:05 | Main_Ind_As_532331_611201911431.xml |
| Results XBRL (BSE) | 2019-09-30 | Standalone | 2019-11-06T12:13:05 | Main_Ind_As_532331_611201911529.xml |
| Results XBRL (BSE) | 2019-12-31 | Consolidated | 2020-02-06T11:38:40 | Main_Ind_As_532331_622020105141.xml |
| Results XBRL (BSE) | 2019-12-31 | Standalone | 2020-02-06T11:38:40 | Main_Ind_As_532331_622020105224.xml |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-05-21T13:32:55 | Main_Ind_As_532331_2152020113331.xml |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-05-21T13:32:55 | Main_Ind_As_532331_2152020113435.xml |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-07-31T12:14:54 | Main_Ind_As_532331_3172020103344.xml |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-07-31T12:14:54 | Main_Ind_As_532331_317202010336.xml |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-11-04T15:05:42 | Main_Ind_As_532331_411202015419.xml |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-11-04T15:05:42 | Main_Ind_As_532331_41120201556.xml |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-03T11:36:16 | Main_Ind_As_532331_3220211003.xml |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-03T11:36:16 | Main_Ind_As_532331_3220211018.xml |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-05-03T13:27:26 | Main_Ind_As_532331_152021143054.xml |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-05-03T13:27:26 | Main_Ind_As_532331_152021143221.xml |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-07-30T12:18:32 | Main_Ind_As_532331_3072021115411.xml |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-07-30T12:18:32 | Main_Ind_As_532331_3072021115520.xml |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-11-01T11:48:45 | Main_Ind_As_532331_1112021112842.xml |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-11-01T11:48:45 | Main_Ind_As_532331_111202193220.xml |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-01-31T18:18:07 | Main_Ind_As_532331_3112022173627.xml |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-01-31T18:18:07 | Main_Ind_As_532331_3112022173712.xml |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-11T12:36:01 | Main_Ind_As_532331_1152022102719.xml |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-11T12:36:01 | Main_Ind_As_532331_1152022102940.xml |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-07-29T12:47:20 | Main_Ind_As_532331_2972022101451.xml |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-07-29T12:47:20 | Main_Ind_As_532331_2972022101549.xml |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-04T15:08:48 | Main_Ind_As_532331_4112022103958.xml |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-04T15:08:48 | Main_Ind_As_532331_4112022104111.xml |
| Annual report | 1999-03-31 | grade B | nan | AJANTA_PHARMA_LTD-532331-MARCH-1999.PDF |
| Annual report | 2000-03-31 | grade A | nan | AJANTA_PHARMA_LTD-532331-MARCH-2000.PDF |
| Annual report | 2001-03-31 | grade A | nan | AJANTA_PHARMA_LTD-532331-MARCH-2001.PDF |
| Annual report | 2003-03-31 | grade A | nan | AJANTA_PHARMA_LTD-532331-MARCH-2003.PDF |
| Annual report | 2004-03-31 | grade A | nan | AJANTA_PHARMA_LTD-532331-MARCH-2004.PDF |
| Annual report | 2005-03-31 | grade A | nan | AJANTA_PHARMA_LTD-532331-MARCH-2005.PDF |
| Annual report | 2006-03-31 | grade A | nan | AJANTA_PHARMA_LTD-532331-MARCH-2006.PDF |
| Annual report | 2010-03-31 | grade A | nan | 5323310310.pdf |
| Annual report | 2011-03-31 | grade A | 2011-12-08T00:00:00 | 5323310311.pdf |
| Annual report | 2012-03-31 | grade A | 2012-06-08T00:00:00 | 5323310312.pdf |
| Annual report | 2013-03-31 | grade A | 2013-06-27T00:00:00 | 5323310313.pdf |
| Annual report | 2014-03-31 | grade A | 2014-07-04T00:00:00 | 5323310314.pdf |
| Annual report | 2015-03-31 | grade B | 2015-06-09T00:00:00 | 5323310315.pdf |
| Annual report | 2016-03-31 | grade A | 2016-07-05T00:00:00 | 5323310316.pdf |
| Annual report | 2017-03-31 | grade A | 2017-07-05T00:00:00 | 5323310317.pdf |
| Annual report | 2018-03-31 | grade A | 2018-07-05T00:00:00 | 5323310318.pdf |
| Annual report | 2019-03-31 | grade A | 2019-06-20T00:00:00 | 5323310319.pdf |
| Annual report | 2020-03-31 | grade A | 2020-06-30T00:00:00 | 5323310320.pdf |
| Annual report | 2021-03-31 | grade A | 2021-06-15T00:00:00 | 68571532331.pdf |
| Annual report | 2022-03-31 | grade A | 2022-07-06T00:00:00 | 73503532331.pdf |
| Annual report | 2023-03-31 | grade A | 2023-06-16T12:36:46.013 | b20f31a7-e77a-42e1-9eeb-ccdb0a7b3320.pdf |
| Annual report | 2024-03-31 | grade A | 2024-06-18T14:15:03.283 | 34cfa17e-5471-4104-8264-eddcbd1dfd1e.pdf |
| Annual report | 2025-03-31 | grade A | 2025-06-18T14:11:06.737 | d052b71a-1a88-4eb9-9613-be4da52ec369.pdf |
| Annual report | 2026-03-31 | grade A | 2026-06-18T10:49:36.74 | 9aa8b4aa-2d68-4133-aca5-456656e479a3.pdf |
| Concall | 2021-03-31 | COVER_LETTER | — | Date_20210504_Ajanta Pharmaceuticals Ltd._Concal_Q4FY21.pdf |
| Concall | 2021-06-30 | COVER_LETTER | — | Date_20210722_Ajanta Pharmaceuticals Ltd._Concal_Q1FY22.pdf |
| Concall | 2021-06-30 | COVER_LETTER | — | Date_20210802_Ajanta Pharmaceuticals Ltd._Concal_Q1FY22.pdf |
| Concall | 2021-09-30 | COVER_LETTER | — | Date_20211108_Ajanta Pharmaceuticals Ltd._Concal_Q2FY22.pdf |
| Concall | 2021-12-31 | COVER_LETTER | — | Date_20220204_Ajanta Pharmaceuticals Ltd._Concal_Q3FY22.pdf |
| Concall | 2022-03-31 | COVER_LETTER | — | Date_20220514_Ajanta Pharmaceuticals Ltd._Concal_Q4FY22.pdf |
| Concall | 2022-06-30 | TRANSCRIPT | — | Date_20220803_Ajanta Pharmaceuticals Ltd._Concal_Q1FY23.pdf |
| Concall | 2022-09-30 | COVER_LETTER | — | Date_20221110_Ajanta Pharmaceuticals Ltd._Concal_Q2FY23.pdf |
| Concall | 2022-12-31 | COVER_LETTER | — | Date_20230213_Ajanta Pharmaceuticals Ltd._Concal_Q3FY23.pdf |
| Concall | 2023-03-31 | COVER_LETTER | — | Date_20230511_Ajanta Pharmaceuticals Ltd._Concal_Q4FY23.pdf |
| Concall | 2023-06-30 | COVER_LETTER | — | Date_20230802_Ajanta Pharmaceuticals Ltd._Concal_Q1FY24.pdf |
| Concall | 2023-09-30 | COVER_LETTER | — | Date_20231103_Ajanta Pharmaceuticals Ltd._Concal_Q2FY24.pdf |
| Concall | 2023-12-31 | COVER_LETTER | — | Date_20240205_Ajanta Pharmaceuticals Ltd._Concal_Q3FY24.pdf |
| Concall | 2024-03-31 | COVER_LETTER | — | Date_20240508_Ajanta Pharmaceuticals Ltd._Concal_Q4FY24.pdf |
| Concall | 2024-06-30 | COVER_LETTER | — | Date_20240802_Ajanta Pharmaceuticals Ltd._Concal_Q1FY25.pdf |
| Concall | 2024-09-30 | COVER_LETTER | — | Date_20241030_Ajanta Pharmaceuticals Ltd._Concal_Q2FY25.pdf |
| Concall | 2024-12-31 | COVER_LETTER | — | Date_20250203_Ajanta Pharmaceuticals Ltd._Concal_Q3FY25.pdf |
| Concall | 2025-03-31 | COVER_LETTER | — | Date_20250505_Ajanta Pharmaceuticals Ltd._Concal_Q4FY25.pdf |
| Concall | 2025-06-30 | COVER_LETTER | — | Date_20250731_Ajanta Pharmaceuticals Ltd._Concal_Q1FY26.pdf |
| Concall | 2025-09-30 | COVER_LETTER | — | Date_20251106_Ajanta Pharmaceuticals Ltd._Concal_Q2FY26.pdf |
| Concall | 2025-12-31 | COVER_LETTER | — | Date_20260205_Ajanta Pharmaceuticals Ltd._Concal_Q3FY26.pdf |
| Concall | 2026-03-31 | COVER_LETTER | — | Date_20260508_Ajanta Pharmaceuticals Ltd._Concal_Q4FY26.pdf |
| Concall | 2026-06-30 | COVER_LETTER | — | Date_20260803_Ajanta Pharmaceuticals Ltd._Concal_Q1FY27.pdf |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_161879_532865_14102021024824_WEB.xml |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_164167_583796_12012022104615_WEB.xml |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_166571_631086_12042022120544_WEB.xml |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169367_688522_14072022124307_WEB.xml |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_171011_720757_10102022043448_WEB.xml |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_174329_767579_16012023030450_WEB.xml |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176271_815605_12042023022235_WEB.xml |
| Shareholding XBRL | 2023-04-19 | — | — | SHP_178064_833012_26042023104447_WEB.xml |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_178316_876115_07072023041937_WEB.xml |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_180901_944965_10102023021257_WEB.xml |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183938_1017797_12012024122802_WEB.xm |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_186511_1089834_12042024050414_WEB.xm |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_189192_1181594_12072024122138_WEB.xm |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_191533_1264746_10102024035931_WEB.xm |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_193931_1338707_07012025042812_WEB.xm |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_196632_1410929_09042025041226_WEB.xm |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1485343_17072025033256_WEB.xml |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1547486_14102025034050_WEB.xml |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1598406_12012026114131_WEB.xml |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1649511_13042026112752_WEB.xml |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1692098_14072026024314_WEB.xml |
| Related-party XBRL | 2022-03-31 | — | — | RPT_AJANTPHARM_25072022142026.xml |
| Related-party XBRL | 2022-09-30 | — | — | RPT_AJANTPHARM_14112022163351.xml |
| Related-party XBRL | 2023-03-31 | — | — | RPT_837936_05052023051626_WEB.xml |
| Related-party XBRL | 2023-09-30 | — | — | RPT_972318_31102023051714_WEB.xml |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1114031_02052024072244_WEB.xml |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1291167_28102024061725_WEB.xml |